Anemia of chronic disease future or investigational therapies

Anemia of chronic disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anemia of chronic disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography or Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anemia of chronic disease future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anemia of chronic disease future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anemia of chronic disease future or investigational therapies
CDC on Anemia of chronic disease future or investigational therapies
Anemia of chronic disease future or investigational therapies in the news
Blogs on Anemia of chronic disease future or investigational therapies
Directions to Hospitals Treating Anemia of chronic disease
Risk calculators and risk factors for Anemia of chronic disease future or investigational therapies

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. Investigational Therapy

• Use of agents that alter the function of hepcidin such as hepcidin antagonists.
• Agents that alter the function of hepcidin receptor (ferroportin) in order to manage the level of hepcidin.

References

Template:WikiDoc Sources